Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Arctic Bioscience AS ( (DE:9TD) ) has issued an announcement.
Arctic Bioscience AS has announced its Annual General Meeting scheduled for May 26, 2025, to be held digitally. Shareholders are encouraged to vote in advance or grant proxy to the Chair of the Board. The meeting will address the reelection of current board members and the nomination of Olav Sindre Kriken, a seasoned entrepreneur with expertise in business innovation and digital strategy, aligning with the company’s growth strategy in product sales and AI utilization.
More about Arctic Bioscience AS
Arctic Bioscience is a biotech company specializing in the development and commercialization of pharmaceutical and nutraceutical products derived from unique bioactive marine compounds. The company is working on HRO350, an innovative oral drug candidate aimed at treating mild-to-moderate psoriasis, and markets nutraceuticals globally under the ROMEGA® brand.
YTD Price Performance: 42.15%
Average Trading Volume: 93,291
Current Market Cap: NOK69.39M
See more data about 9TD stock on TipRanks’ Stock Analysis page.